Thanks for the reply Sweatpea. From what I read in

Thanks for the reply Sweatpea. From what I read in the article and IMHO, that stock drop was a knee jerk reaction to one negative study result. And having a placebo get such high results against the trial is under investigation also this is only ONE CBD compound (CBDV) used for epilepsy in adults only. I think the results will only affect GW and only for a moment as their trial for children with severe forms of epilepsy was a success. Overall IMO CBDs for general health maintenance will still continue on an upward trend.

Thanks for the article and reply!